Regulatory News
Thursday, February 2, 2017
BRIEF-CME Group CEO on CNBC - Some parts of Dodd-Frank don't need to be changed
›
* CME Group CEO Terry Duffy on CNBC - Some parts of Dodd-Frank don't need to be changed Read more
UPDATE 1-EU set to approve ChemChina's $43 bln bid for Syngenta - sources
›
BRUSSELS, Feb 2 (Reuters) - ChemChina is set to secure conditional EU antitrust approval for its $43 billion bid for Swiss pesticides and se...
BRIEF-Amir Efrati reports 7.5 pct stake in Alcobra Ltd as of Jan. 23
›
* Amir Efrati reports 7.5 percent stake in Alcobra Ltd as of January 23 - sec filing Read more
BRIEF-Metlife investment portollo starting to benefit from higher interest rates, ceo says
›
* Investment portollo starting to benefit from higher interest rates, ceo says Read more
UPDATE 1-British Brexit paper stresses hope for mutual EU/UK benefit
›
LONDON, Feb 2 (Reuters) - Britain will do its utmost to negotiate a divorce deal with the European Union that is mutually beneficial, Brexit...
BRIEF-Teva confirms generic Victoza patent challenge in the United States
›
* Teva confirms generic Victoza patent challenge in the united states Read more
BRIEF-Cytomx announces the first patient treated in phase 1/2 proclaim-072 trial
›
* Cytomx announces the first patient treated in phase 1/2 proclaim-072 trial Source text for Eikon: Further company coverage: Read more
›
Home
View web version